Published in Laryngoscope on May 17, 2013
Medial sural artery perforator flap: a challenging free flap. Eur J Plast Surg (2015) 0.75
Midfacial Reconstruction - A Systematic Review. Open Access Maced J Med Sci (2016) 0.75
Value of the Post-Operative CT in Predicting Delayed Flap Failures Following Head and Neck Cancer Surgery. Korean J Radiol (2017) 0.75
Locoregional and Microvascular Free Tissue Reconstruction of the Lateral Skull Base. Semin Plast Surg (2017) 0.75
Outcome after pharyngeal reconstruction using pectoralis major and radial forearm flap after resection of pharyngeal and laryngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol (2015) 0.75
Head and neck reconstructive surgery: what the radiologist needs to know. Eur Radiol (2016) 0.75
Reconstruction of dorsal hand and finger defects with reverse radial fasciocutaneous forearm flaps. Eur J Orthop Surg Traumatol (2014) 0.75
Simplifying microvascular head and neck reconstruction: a rational approach to donor site selection. Ann Plast Surg (2001) 1.75
Analytic review of 2372 free flap transfers for head and neck reconstruction following cancer resection. J Reconstr Microsurg (2003) 1.61
Mandible reconstruction with microvascular surgery. Semin Surg Oncol (2001) 1.23
Free flap reconstruction of the head and neck: analysis of 241 cases. Otolaryngol Head Neck Surg (2001) 1.18
Microvascular free flaps: a major advance in head and neck reconstruction. Acta Otolaryngol (2002) 1.07
Complications of free flap transfers for head and neck reconstruction following cancer resection. Oral Oncol (2004) 1.06
Reconstruction of defects in the head and neck with free flaps: 20 years experience. Br J Oral Maxillofac Surg (2006) 1.05
Microvascular free flaps in head and neck surgery: complications and outcome of 1000 flaps. Int J Oral Maxillofac Surg (2012) 1.04
Predictors of complications of free flap reconstruction in head and neck surgery: Analysis of 304 free flap reconstruction procedures. Laryngoscope (2012) 0.99
Definitive management of severe facial trauma utilizing free tissue transfer. Otolaryngol Head Neck Surg (2005) 0.96
Management of extensive osteoradionecrosis of the mandible with radical resection and immediate microvascular reconstruction. J Oral Maxillofac Surg (2007) 0.92
Free flap reconstruction of lateral mandibular defects: indications and outcomes. Otolaryngol Head Neck Surg (2011) 0.91
Simplifying head and neck microvascular reconstruction. Head Neck (2004) 0.90
Functional outcomes of fibula and osteocutaneous forearm free flap reconstruction for segmental mandibular defects. Laryngoscope (2010) 0.89
The role of the osteocutaneous radial forearm free flap in the treatment of mandibular osteoradionecrosis. Otolaryngol Head Neck Surg (2005) 0.88
Free flap reconstruction of self-inflicted submental gunshot wounds. Craniomaxillofac Trauma Reconstr (2011) 0.85
Immediate reconstruction of the cervical esophagus by a revascularized isolated jejunal segment. Surg Forum (1958) 0.79
Impact of pharyngeal closure technique on fistula after salvage laryngectomy. JAMA Otolaryngol Head Neck Surg (2013) 2.37
Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma. Mol Imaging Biol (2013) 1.67
Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg (2011) 1.62
Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life. Laryngoscope (2006) 1.59
Stereomicroscopic fluorescence imaging of head and neck cancer xenografts targeting CD147. Cancer Biol Ther (2008) 1.57
Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2008) 1.56
Complete vasomotor collapse: an unusual manifestation of the carotid sinus reflex. Anesthesiology (2003) 1.53
Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg (2010) 1.52
In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence. Laryngoscope (2006) 1.50
Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope (2012) 1.49
Dynasplint for the management of trismus after treatment of upper aerodigestive tract cancer: a retrospective study. Ear Nose Throat J (2011) 1.45
Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck (2008) 1.42
Utility of CT surveillance for primary site recurrence of squamous cell carcinoma of the head and neck. Head Neck (2010) 1.39
Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Arch Otolaryngol Head Neck Surg (2007) 1.33
Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol (2012) 1.30
Functional outcomes after transoral robotic surgery for head and neck cancer. Otolaryngol Head Neck Surg (2009) 1.29
Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment. Int J Radiat Oncol Biol Phys (2008) 1.27
Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma. Laryngoscope (2003) 1.22
Pectoralis major myocutaneous flap vs revascularized free tissue transfer: complications, gastrostomy tube dependence, and hospitalization. Arch Otolaryngol Head Neck Surg (2004) 1.19
The role of free tissue transfer in the reconstruction of massive neglected skin cancers of the head and neck. Arch Facial Plast Surg (2003) 1.17
Prophylactic percutaneous endoscopic gastrostomy tube placement in treatment of head and neck cancer: a comprehensive review and call for evidence-based medicine. JPEN J Parenter Enteral Nutr (2011) 1.16
Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer (2006) 1.16
Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment. Cancer Biol Ther (2007) 1.16
Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure. Laryngoscope (2007) 1.16
Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res (2009) 1.16
Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches. JAMA Otolaryngol Head Neck Surg (2013) 1.14
Use of the endoscopic microdebrider in the management of airway obstruction from laryngotracheal carcinoma. Ann Otol Rhinol Laryngol (2003) 1.11
Transoral robotic-assisted surgery for head and neck squamous cell carcinoma: one- and 2-year survival analysis. Arch Otolaryngol Head Neck Surg (2010) 1.10
Assessment and incidence of salivary leak following laryngectomy. Laryngoscope (2012) 1.10
Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma. Laryngoscope (2011) 1.09
IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques. Mol Imaging Biol (2015) 1.08
Learning curve for transoral robotic surgery: a 4-year analysis. JAMA Otolaryngol Head Neck Surg (2013) 1.06
Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope (2013) 1.04
Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines. Otolaryngol Head Neck Surg (2007) 1.00
Perceptions of harm to health from cigarettes, blunts, and marijuana among young adult African American men. J Health Care Poor Underserved (2013) 0.98
Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice. Clin Exp Metastasis (2004) 0.98
Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice. Otolaryngol Head Neck Surg (2013) 0.97
Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer. Laryngoscope (2010) 0.97
(18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Mol Imaging Biol (2012) 0.96
Disruptions in the organization of meal preparation and consumption among older cancer patients and their family caregivers. Psychooncology (2010) 0.96
Incidence and outcomes of stricture formation postlaryngectomy. Otolaryngol Head Neck Surg (2011) 0.95
Expandable tracheal stenting for benign disease: worth the complications? Ann Otol Rhinol Laryngol (2006) 0.94
Closure of post-laryngectomy pharyngocutaneous fistulae. Head Neck Oncol (2011) 0.94
EGFR expression in advanced head and neck cutaneous squamous cell carcinoma. Head Neck (2011) 0.93
Outcomes following temporal bone resection. Laryngoscope (2010) 0.93
Optical imaging predicts tumor response to anti-EGFR therapy. Cancer Biol Ther (2010) 0.93
Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biol Ther (2013) 0.92
Social networking and professionalism in otolaryngology residency applicants. Laryngoscope (2012) 0.92
Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer. Arch Otolaryngol Head Neck Surg (2008) 0.92
Extracellular matrix metalloprotease inducer-expressing head and neck squamous cell carcinoma cells promote fibroblast-mediated type I collagen degradation in vitro. Mol Cancer Res (2005) 0.92
Free flap reconstruction of lateral mandibular defects: indications and outcomes. Otolaryngol Head Neck Surg (2011) 0.91
Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis. J Oral Pathol Med (2014) 0.91
Expression of proteolytic enzymes in head and neck cancer-associated fibroblasts. Arch Otolaryngol Head Neck Surg (2004) 0.91
Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells. Mol Cancer Res (2011) 0.91
Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model. Anticancer Drugs (2010) 0.91
Robot-assisted surgery for upper aerodigestive tract neoplasms. Arch Otolaryngol Head Neck Surg (2009) 0.90
Transoral robotic surgery for oropharyngeal and tongue cancer in the United States. Laryngoscope (2014) 0.90
CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma. Exp Cell Res (2012) 0.90
Gastrostomy tube placement and use in patients with head and neck cancer. Head Neck (2011) 0.90
Primary versus delayed tracheoesophageal puncture for laryngopharyngectomy with free flap reconstruction. Laryngoscope (2011) 0.90
Zygomatic-maxillary buttress reconstruction of midface defects with the osteocutaneous radial forearm free flap. Head Neck (2008) 0.90
Influence of social support on health-related quality of life outcomes in head and neck cancer. Head Neck (2007) 0.90
Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy. Anticancer Drugs (2011) 0.89
Functional outcomes of fibula and osteocutaneous forearm free flap reconstruction for segmental mandibular defects. Laryngoscope (2010) 0.89
Management of the N0 neck in recurrent laryngeal squamous cell carcinoma. Laryngoscope (2010) 0.88
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer. Head Neck (2011) 0.88
Current strategies in reconstruction of maxillectomy defects. Arch Otolaryngol Head Neck Surg (2011) 0.88